Schall Thomas J. 4
4 · Immuneering Corp · Filed Jun 18, 2025
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Schall Thomas J.
Director
Transactions
- Purchase
Class A Common Stock
2025-06-17$2.21/sh+40,485$89,278→ 43,385 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.16 to $2.24. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.